The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative
about
Endothelin-1 and its role in the pathogenesis of infectious diseasesVascular dysfunction as a target for adjuvant therapy in cerebral malariaEndothelin-1 Mediates Brain Microvascular Dysfunction Leading to Long-Term Cognitive Impairment in a Model of Experimental Cerebral MalariaExperimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierThe Einstein-Brazil Fogarty: A decade of synergyRole of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infectionPathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.A new hypothesis on the manifestation of cerebral malaria: the secret is in the liverPotential efficacy of citicoline as adjunct therapy in treatment of cerebral malaria.Local mild hypothermia therapy as an augmentation strategy for minimally invasive surgery of hypertensive intracerebral hemorrhage: a meta-analysis of randomized clinical trialsCerebral malaria: we have come a long wayFatal cerebral malaria: a venous efflux problem.The immunological balance between host and parasite in malaria.Neuroinflammation and Infection: Molecular Mechanisms Associated with Dysfunction of Neurovascular Unit.Endothelin-1 Treatment Induces an Experimental Cerebral Malaria-Like Syndrome in C57BL/6 Mice Infected with Plasmodium berghei NK65.
P2860
Q26830339-4D2EFD54-45DD-40A3-AC1C-56687011B2C2Q27025436-A469022A-6FCC-4EDB-91ED-9F190005EB6EQ27315202-D31DB767-5F78-43B1-A34B-D502805780B6Q27322655-6FF6968F-D672-4860-9917-924A3752D5F3Q28083306-661C6143-5774-4B44-9DEF-BA7446901771Q34058953-BE77E729-F56E-417E-8966-4F560ACED084Q36209383-6F0D0521-D0A8-46C8-BC2A-B6320989D26AQ37281876-0F6B5AEC-DED2-4ACA-BB62-0AA9CEE1A169Q37544546-1B1D0353-1135-4B5B-B9A4-D95E1F9C4561Q37551942-833FA1A9-E583-4228-AB9E-225998945290Q38047587-2E440914-5E01-4743-9508-4F4532E16815Q38270197-E6AF5CCC-78C7-4588-A1AA-89FDD0C7905EQ38666558-7B6A75A9-DF8E-4929-8048-E4A0BEBBFA50Q38693771-84E59B53-3D65-41BA-9610-5FBDBF1E4D76Q40480110-349C0FC6-14C9-4AC2-99B0-D66AEE1D7375
P2860
The novel ETA receptor antagonist HJP-272 prevents cerebral microvascular hemorrhage in cerebral malaria and synergistically improves survival in combination with an artemisinin derivative
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The novel ETA receptor antagon ...... with an artemisinin derivative
@ast
The novel ETA receptor antagon ...... with an artemisinin derivative
@en
type
label
The novel ETA receptor antagon ...... with an artemisinin derivative
@ast
The novel ETA receptor antagon ...... with an artemisinin derivative
@en
prefLabel
The novel ETA receptor antagon ...... with an artemisinin derivative
@ast
The novel ETA receptor antagon ...... with an artemisinin derivative
@en
P2093
P2860
P50
P921
P1433
P1476
The novel ETA receptor antagon ...... with an artemisinin derivative
@en
P2093
Brandi Freeman
Henry J Shikani
Louis M Weiss
Minxian Dai
Ralph A Stephani
Sandra E Reznik
P2860
P304
P356
10.1016/J.LFS.2012.07.006
P407
P577
2012-07-17T00:00:00Z